Sensible Biotechnologies, Inc.
Claymont, DE · Founded 2021 · CIK 0001964363 · Biotech · Private
mRNA design, optimisation and manufacturing platform for mRNA therapeutics
sensible.bio →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $15M
- 2 Form D · Sep 2026
- 1 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 5
- 0 granted · 5 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓202220232024202520262027
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $1,829,000 | |
| Private capital raised | Form D · SEC | $13,518,941 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1720 | SAMBA BIOLOGICS INC. | — | — |
| 1721 | AAVOGEN INC | — | — |
| 1722 | Emergo Therapeutics, Inc. | — | $4.0M |
| 1723 | Sensible Biotechnologies, Inc. | — | $15M |
| 1724 | Pulmocide | — | — |
| 1725 | Jaguar Gene Therapy | — | — |
| 1726 | FAUNA BIO INCORPORATED | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Miroslav GasparekDirector · Executive Officer
- Marian KupculakDirector · Executive Officer
Patents
- Methods And Systems For Heterologous Rna Payload Production In Virus-like Particles In The Yeast Genus Yarrowiaapplication
- Methods And Systems For Rna Encapsulation To Increase Rna Stability And Translation Efficiencyapplication
- Methods And Systems For Heterologous Rna Payload Production In Virus-like Particles In The Yeast Genus Yarrowiaapplication
- Methods And Systems For Rna Encapsulation To Increase Rna Stability And Translation Efficiencyapplication
- Methods And Systems For Rna Encapsulation To Increase Rna Stability And Translation Efficiencyapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.